{"schema_version":"secwatch.filing_event.v1","accession":"0001171520-22-000351","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2022-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.085230+00:00","generated_at":"2026-06-25T06:39:11.288865+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"ClearPoint Neuro stockholders approve authorized share reduction from 200M to 80M","bullets":["Authorized common shares reduced from 200M to 80M via Certificate of Amendment.","Eight directors elected, including Joseph Burnett, R. John Fletcher, and Matthew Klein.","Cherry Bekaert LLP ratified as independent auditor for FY 2022; 15.8M for, 19.6K against.","Fourth Amended and Restated 2013 Incentive Compensation Plan approved (8.7M for).","Advisory vote on executive compensation approved with 8.6M for, 887K against."],"urls":{"canonical":"https://secwatch.observer/filing/0001171520-22-000351","json":"https://secwatch.observer/filing/0001171520-22-000351.json","markdown":"https://secwatch.observer/filing/0001171520-22-000351.md","text":"https://secwatch.observer/filing/0001171520-22-000351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/0001171520-22-000351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/eps10282.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T06:39:11.288865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}